search
Back to results

Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

Primary Purpose

Pain, Postoperative, Amputation

Status
Recruiting
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Liposomal bupivacaine
Bupivacaine Hydrochloride 0.5 % Injectable Solution
Sponsored by
Ryan Mountjoy, MD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Pain, Postoperative

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • American Society of Anesthesiologists Physical Status Classification I-IV
  • Scheduled for primary amputation or stump revision
  • English speaking

Exclusion Criteria:

  • Patients unable to cooperate or consent to the study
  • Allergy to local anesthetics
  • Existing infection at planned needle insertion site
  • BMI > 40kg/m2
  • Patients with a history of coagulopathy
  • Emergency amputations
  • Contralateral amputations
  • Patients with a substance use disorder diagnosis
  • Patients on opioids >90 morphine milligram equivalents (MME)/day

Sites / Locations

  • Maine Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Single Shot Perineural Popliteal Nerve Block

Continuous perineural popliteal nerve block catheter

Arm Description

Single shot perineural popliteal nerve block injection of 10cc 13.3% liposomal bupivacaine combined with 15cc 0.50% bupivacaine hydrochloride within one hour prior to surgery

Placement of continuous perineural popliteal nerve block catheter with injection of 30cc 0.5% bupivacaine within one hour prior to surgery, followed by continuous infusion of 10cc 0.3% ropivacaine (current standard practice) for at least 72 hours following surgery. Saphenous single shot 20cc 0.2

Outcomes

Primary Outcome Measures

Pain assessed by Numerical Rating Scale (NRS)
Average NRS pain scores (0-10, 0=no pain, 10=worst possible pain)

Secondary Outcome Measures

Opioid Consumption
Total amount of opioid medication given, in morphine milligram equivalents
Post-operative Length of Stay
Length of stay in hours
Post-operative Pain assessed by the Short Form McGill Pain Questionnaire-2 (SFMPQ-2)
Total SFMPQ-2 score (low score of 0, no pain to a high score of 220, worst possible pain)
Phantom Limb Pain assessed using questions from the Trinity Amputation and Prosthesis Experiences Scales-Revised (TAPES-R)
Measured using questions 4 and 5 from Part II of the TAPES-R (scores can range from 0, no pain, to 22, severe pain)

Full Information

First Posted
October 25, 2021
Last Updated
February 21, 2023
Sponsor
Ryan Mountjoy, MD
Collaborators
MaineHealth
search

1. Study Identification

Unique Protocol Identification Number
NCT05140499
Brief Title
Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations
Official Title
A Prospective, Randomized Trial of Liposomal Bupivacaine Compared to Continuous Nerve Catheters on Pain Control and Post-Operative Opioid Use in Receiving Popliteal Nerve Blocks for Below the Knee Amputation
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 15, 2022 (Actual)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Ryan Mountjoy, MD
Collaborators
MaineHealth

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Through this pilot prospective trial, we aim to obtain preliminary data investigating the effectiveness of perineural catheters and liposomal bupivacaine, both currently accepted as standard care at Maine Medical Center, for the management of post-limb amputation pain. We will use the data that we collect to inform the design of a larger, appropriately powered study.
Detailed Description
Lower extremity amputation is a common surgical procedure often due to limb ischemia or complications related to diabetes mellitus. Managing postoperative pain can be quite challenging in this patient population and persistent post-surgical pain is not uncommon. Peripheral nerve catheters (PNCs) that deliver a continuous infusion of local anesthetic have been shown to provide analgesic benefit dependent upon infusion duration and in the absence of catheter malfunction. Unfortunately, PNCs can be difficult to place and rates of dislodgement are estimated at 30%. Single shot regional nerve blocks using liposomal bupivacaine are much easier to perform than PNCs and can provide up to 72 hours of pain relief, eliminating the need for catheter placement. To date, no study has investigated the effects of liposomal bupivacaine compared to PNCs for post-surgical pain control. In this pilot study, we intend to compare pain scores, opioid consumption, and length of stay in patients randomized to both treatment strategies. We also intend to conduct an exploratory analysis investigating incidence of phantom limb pain one month following surgery. Our results will inform the design of a larger powered study to investigate treatment effects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Postoperative, Amputation

7. Study Design

Primary Purpose
Other
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Single Shot Perineural Popliteal Nerve Block
Arm Type
Active Comparator
Arm Description
Single shot perineural popliteal nerve block injection of 10cc 13.3% liposomal bupivacaine combined with 15cc 0.50% bupivacaine hydrochloride within one hour prior to surgery
Arm Title
Continuous perineural popliteal nerve block catheter
Arm Type
Active Comparator
Arm Description
Placement of continuous perineural popliteal nerve block catheter with injection of 30cc 0.5% bupivacaine within one hour prior to surgery, followed by continuous infusion of 10cc 0.3% ropivacaine (current standard practice) for at least 72 hours following surgery. Saphenous single shot 20cc 0.2
Intervention Type
Drug
Intervention Name(s)
Liposomal bupivacaine
Other Intervention Name(s)
Exparel
Intervention Description
Popliteal nerve block
Intervention Type
Drug
Intervention Name(s)
Bupivacaine Hydrochloride 0.5 % Injectable Solution
Other Intervention Name(s)
conventional bupivacaine
Intervention Description
Continuous nerve catheter
Primary Outcome Measure Information:
Title
Pain assessed by Numerical Rating Scale (NRS)
Description
Average NRS pain scores (0-10, 0=no pain, 10=worst possible pain)
Time Frame
72 hours post-operatively
Secondary Outcome Measure Information:
Title
Opioid Consumption
Description
Total amount of opioid medication given, in morphine milligram equivalents
Time Frame
72 hours post-operatively
Title
Post-operative Length of Stay
Description
Length of stay in hours
Time Frame
Measured from surgical stop time to discharge time, an average of 5 days.
Title
Post-operative Pain assessed by the Short Form McGill Pain Questionnaire-2 (SFMPQ-2)
Description
Total SFMPQ-2 score (low score of 0, no pain to a high score of 220, worst possible pain)
Time Frame
30 days following surgery
Title
Phantom Limb Pain assessed using questions from the Trinity Amputation and Prosthesis Experiences Scales-Revised (TAPES-R)
Description
Measured using questions 4 and 5 from Part II of the TAPES-R (scores can range from 0, no pain, to 22, severe pain)
Time Frame
30 days following surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American Society of Anesthesiologists Physical Status Classification I-IV Scheduled for primary amputation or stump revision English speaking Exclusion Criteria: Patients unable to cooperate or consent to the study Allergy to local anesthetics Existing infection at planned needle insertion site BMI > 40kg/m2 Patients with a history of coagulopathy Emergency amputations Contralateral amputations Patients with a substance use disorder diagnosis Patients on opioids >90 morphine milligram equivalents (MME)/day
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Janelle M Richard
Phone
2076622862
Email
richaj3@mmc.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ryan Mountjoy, MD
Organizational Affiliation
MaineHealth
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maine Medical Center
City
Portland
State/Province
Maine
ZIP/Postal Code
04102
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Janelle Richard
Phone
207-662-2862
Email
richaj3@mmc.org
First Name & Middle Initial & Last Name & Degree
Ryan Mountjoy, MD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
Citation
Neil MJE. Pain after amputation. BJA Education. 2016: 16(3):107-12.
Results Reference
background
PubMed Identifier
27703632
Citation
Borg L, Howard SK, Kim TE, Steffel L, Shum C, Mariano ER. A comparison of strength for two continuous peripheral nerve block catheter dressings. Korean J Anesthesiol. 2016 Oct;69(5):506-509. doi: 10.4097/kjae.2016.69.5.506. Epub 2016 Jul 25.
Results Reference
background
PubMed Identifier
20881281
Citation
Borghi B, D'Addabbo M, White PF, Gallerani P, Toccaceli L, Raffaeli W, Tognu A, Fabbri N, Mercuri M. The use of prolonged peripheral neural blockade after lower extremity amputation: the effect on symptoms associated with phantom limb syndrome. Anesth Analg. 2010 Nov;111(5):1308-15. doi: 10.1213/ANE.0b013e3181f4e848. Epub 2010 Sep 29.
Results Reference
background
PubMed Identifier
21821511
Citation
Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011 Oct;113(4):904-25. doi: 10.1213/ANE.0b013e3182285e01. Epub 2011 Aug 4.
Results Reference
background
PubMed Identifier
21620338
Citation
Ilfeld BM. Continuous peripheral nerve blocks in the hospital and at home. Anesthesiol Clin. 2011 Jun;29(2):193-211. doi: 10.1016/j.anclin.2011.04.003.
Results Reference
background
PubMed Identifier
22570563
Citation
Bergese SD, Ramamoorthy S, Patou G, Bramlett K, Gorfine SR, Candiotti KA. Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res. 2012;5:107-16. doi: 10.2147/JPR.S30861. Epub 2012 May 1.
Results Reference
background
PubMed Identifier
31791561
Citation
Prabhakar A, Ward CT, Watson M, Sanford J, Fiza B, Moll V, Kaye RJ, Morgan Hall O, Cornett EM, Urman RD, Kaye AD. Liposomal bupivacaine and novel local anesthetic formulations. Best Pract Res Clin Anaesthesiol. 2019 Dec;33(4):425-432. doi: 10.1016/j.bpa.2019.07.012. Epub 2019 Jul 19. Erratum In: Best Pract Res Clin Anaesthesiol. 2021 Dec;35(4):E1-E2.
Results Reference
background
PubMed Identifier
28430722
Citation
Davidovitch R, Goch A, Driesman A, Konda S, Pean C, Egol K. The Use of Liposomal Bupivacaine Administered With Standard Bupivacaine in Ankle Fractures Requiring Open Reduction Internal Fixation: A Single-Blinded Randomized Controlled Trial. J Orthop Trauma. 2017 Aug;31(8):434-439. doi: 10.1097/BOT.0000000000000862.
Results Reference
background
PubMed Identifier
28694151
Citation
Mazloomdoost D, Pauls RN, Hennen EN, Yeung JY, Smith BC, Kleeman SD, Crisp CC. Liposomal bupivacaine decreases pain following retropubic sling placement: a randomized placebo-controlled trial. Am J Obstet Gynecol. 2017 Nov;217(5):598.e1-598.e11. doi: 10.1016/j.ajog.2017.07.001. Epub 2017 Jul 8.
Results Reference
background
PubMed Identifier
28682872
Citation
Yan Z, Chen Z, Ma C. Liposomal bupivacaine versus interscalene nerve block for pain control after shoulder arthroplasty: A meta-analysis. Medicine (Baltimore). 2017 Jul;96(27):e7226. doi: 10.1097/MD.0000000000007226.
Results Reference
background
PubMed Identifier
33372953
Citation
Hussain N, Brull R, Sheehy B, Essandoh MK, Stahl DL, Weaver TE, Abdallah FW. Perineural Liposomal Bupivacaine Is Not Superior to Nonliposomal Bupivacaine for Peripheral Nerve Block Analgesia. Anesthesiology. 2021 Feb 1;134(2):147-164. doi: 10.1097/ALN.0000000000003651.
Results Reference
background
PubMed Identifier
16698416
Citation
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. doi: 10.1016/S0140-6736(06)68700-X.
Results Reference
background
PubMed Identifier
16691088
Citation
Richardson C, Glenn S, Nurmikko T, Horgan M. Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease. Clin J Pain. 2006 May;22(4):353-8. doi: 10.1097/01.ajp.0000177793.01415.bd.
Results Reference
background
PubMed Identifier
3991231
Citation
Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain. 1985 Mar;21(3):267-278. doi: 10.1016/0304-3959(85)90090-9.
Results Reference
background
PubMed Identifier
17531734
Citation
Madabhushi L, Reuben SS, Steinberg RB, Adesioye J. The efficacy of postoperative perineural infusion of bupivacaine and clonidine after lower extremity amputation in preventing phantom limb and stump pain. J Clin Anesth. 2007 May;19(3):226-9. doi: 10.1016/j.jclinane.2006.07.008.
Results Reference
background
PubMed Identifier
7979074
Citation
Jahangiri M, Jayatunga AP, Bradley JW, Dark CH. Prevention of phantom pain after major lower limb amputation by epidural infusion of diamorphine, clonidine and bupivacaine. Ann R Coll Surg Engl. 1994 Sep;76(5):324-6.
Results Reference
background
PubMed Identifier
11464349
Citation
Lambert Aw, Dashfield Ak, Cosgrove C, Wilkins Dc, Walker Aj, Ashley S. Randomized prospective study comparing preoperative epidural and intraoperative perineural analgesia for the prevention of postoperative stump and phantom limb pain following major amputation. Reg Anesth Pain Med. 2001 Jul-Aug;26(4):316-21. doi: 10.1053/rapm.2001.23934.
Results Reference
background
PubMed Identifier
9365449
Citation
Nikolajsen L, Ilkjaer S, Christensen JH, Kroner K, Jensen TS. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet. 1997 Nov 8;350(9088):1353-7. doi: 10.1016/S0140-6736(97)06315-0.
Results Reference
background
PubMed Identifier
9861117
Citation
Nikolajsen L, Ilkjaer S, Jensen TS. Effect of preoperative extradural bupivacaine and morphine on stump sensation in lower limb amputees. Br J Anaesth. 1998 Sep;81(3):348-54. doi: 10.1093/bja/81.3.348.
Results Reference
background
PubMed Identifier
11953619
Citation
Morey TE, Giannoni J, Duncan E, Scarborough MT, Enneking FK. Nerve sheath catheter analgesia after amputation. Clin Orthop Relat Res. 2002 Apr;(397):281-9. doi: 10.1097/00003086-200204000-00032.
Results Reference
background
PubMed Identifier
19356853
Citation
Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009 Jul;144(1-2):35-42. doi: 10.1016/j.pain.2009.02.007. Epub 2009 Apr 7.
Results Reference
background
Citation
Gallagher P, MacLachlan M. Development and psychometric evaluation of the Trinity Amputation and Prosthesis Experience Scales (TAPES). Rehabilitation Psychology. 2000: 45(2), 130-154.
Results Reference
background
PubMed Identifier
26178637
Citation
Jensen MP, Castarlenas E, Tome-Pires C, de la Vega R, Sanchez-Rodriguez E, Miro J. The Number of Ratings Needed for Valid Pain Assessment in Clinical Trials: Replication and Extension. Pain Med. 2015 Sep;16(9):1764-72. doi: 10.1111/pme.12823. Epub 2015 Jul 14.
Results Reference
background
Citation
Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics. 2005;4(4):287-91.
Results Reference
background

Learn more about this trial

Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

We'll reach out to this number within 24 hrs